dal vid blog

radio spots

injecting rooms

ambo stats

Ambulance
AOD STATS
Interactive
Data Site

Introduction: Welcome to AODstats, the Victorian alcohol and drug interactive statistics and mapping webpage.
AODstats provides information on the harms related to alcohol, illicit and pharmaceutical drug use in Victoria.

For more details
visit the website now

“I feel like I've hit the bottom and have no idea what to do.”: Supportive social networking on Reddit for individuals with a desire to quit cannabis use

Shaina J. Sowles , M.P.H, Melissa J. Krauss , M.P.H, Lewam Gebremedhn & Patricia A. Cavazos-Rehg , Ph.D.

Accepted 03 Feb 2017, Accepted author version posted online: 13 Jul 2017

Conclusions: This exploratory research highlights the potential of online communities as tools for individuals coping with addiction recovery, and future research should investigate if involvement in such communities would be a beneficial supplement to more traditional recovery practices. 

For more

Teenagers who smoke marijuana regularly achieve poorer grades at school and risk their chances of going to university, according to a major new scientific study.

A longitudinal study of more than 26,400 pupils in Canada found those who started using marijuana at least once a month were around half as likely to achieve high grades as they were before taking up the habit, and were ultimately less likely to pursue university ambitions.

Marijuana users were also four times more likely to skip classes and two-to-four times less likely to complete their homework and value getting good grades.

For more

Published July 2017 By Honor Whiteman  

Researchers say that adolescents who increase their use of the drug may be more susceptible to psychotic-like episodes.

Studies have long suggested a link between marijuana use and psychosis. New research sheds further light on this association, after finding that teenagers who increase their use of the drug are more likely to experience psychotic-like episodes…Compared with teenagers in the general population, the researchers found that teenagers who increased their frequency of marijuana use from occasionally to weekly or daily were at 159 percent greater risk of having recurrent PLEs.

For more

(Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators http://onlinelibrary.wiley.com/doi/10.1111/jcpp.12765/full )

Published: 10 July 2017
 
In The Lancet Psychiatry, Schoeler and colleagues present a study describing the mediating effect of medication adherence on the association between continued cannabis use and relapse risk in patients with first-episode psychosis. They have previously reported a relapse rate of 36% in this patient group over a 2-year period.

Acknowledging the potential risk of psychosis relapse related to the high proportion of patients continuing cannabis use after the onset of psychosis, the current study1 investigates the same patient group consisting of 245 patients, obtaining retrospective data on active cannabis use and medication adherence shortly after illness onset, as well as risk of relapse at 2-year follow-up. The authors find that relapse of psychosis associated with continued cannabis use is partly mediated through non-adherence to prescribed antipsychotic medication.

It is well established that cannabis use increases the risk of schizophrenia, not only from the early Swedish conscript studies but also from studies on people who use sinsemilla in London, UK, showing that high potency cannabis increases the risk of schizophrenia. Twin studies from Norway have shown that cannabis increases the risk of psychosis, even when controlling for genetic factors. There has been discussion on the direction of the association, as none of these studies can rule out reverse causality, but it seems reasonable to conclude that cannabis is one of many stressors that can precipitate schizophrenia, at least in susceptible individuals.

For complete Research

6/07/2017 

“What do you want, what do you hate, what’s going to turn you off so I can’t ask you for money?”

This was the question the nation’s top pot lobbyist recently posed to tobacco executives in Michigan, where his lobbying group has drafted language for a recreational marijuana legalization law and is now collecting signatures to place it on the state’s 2018 ballot.

That Rob Kampia, Executive Director of the Marijuana Policy Project (MPP), went on-the-record to admit he asked this of Michigan tobacco companies is both alarming and contemptible. MPP is the lead special interest group responsible for funding and organizing every state-based marijuana commercialization campaign in the U.S. Kampia’s shameless solicitation for contributions from the tobacco industry should send chills down the spine of every American who remembers our painful national experience with Big Tobacco.

The nascent marijuana industry, which has been profiting off of high-potency commercial products, is not only following in Big Tobacco’s footsteps, but now openly admitting to taking money from them.

Make no mistake, the marijuana industry is laying the groundwork to take center stage as Big Tobacco 2.0. Tobacco companies have been eyeing marijuana as the next big addictive enterprise since the 1970’s, and now they’re getting in on this cash cow in the ultimate quid pro quo: taking money in return for shaping the language of today’s marijuana legalization initiatives

For more

  • Victoria
  • Dalgarno Central
    (Coalition of Alcohol & Drug Educators)

    Phone: 1300 975 002
    Fax: 1300 952 551
    Address
    : PO Box 7005
    Dandenong, Vic, 3175


    Contact Us

    Bendigo Campus
    Mobile: 0403 065 686
    Address: PO Box 234,
    Eaglehawk, Vic, 3556


  • New South Wales
  • Hunter VCampus
    Mobile: 0414 506 905
    Address: PO Box 19
    Cooranbong, NSW, 2265


    Sydney VCampus
    Mobile
    : 1300 975 002

    • South Australia
    • SA Campus
      Mobile: 0448 749 800
      Address: 1 Collingrove Ave
      Broadview, SA, 5083
      Latest Newsletter
  • Other
  • P.A.D.D
    Mobile: 1300 975 002